The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:557-559 February 18, 1999 Number 7
NextNext

Growth Hormone Use in Normal, Short Children — A Plea for Reason

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Hintz, R. L.
-PubMed Citation
In the United States, recombinant growth hormone is approved for use in children for three conditions: growth hormone deficiency, Turner's syndrome, and chronic renal insufficiency before transplantation. Because the supply of growth hormone is unlimited and treatment has few adverse effects, it is not surprising that there is interest in treating children with short stature who do not have classic growth hormone deficiency.

But what is short stature? Is it a height that is more than 2 SD below the mean for age and sex (less than the 3rd percentile)? If so, should treatment with growth hormone in an otherwise . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.